Hassan, M.; El-Maadawy, W.H.; Elhusseny, Y.; Agamy, F.E.; Fahim, S.A.; Balata, M.
Genetic Variants and Soluble Isoforms of PD-1/PD-L1 as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma (PDAC) Susceptibility and Prognosis. Biomedicines 2025, 13, 2246.
https://doi.org/10.3390/biomedicines13092246
AMA Style
Hassan M, El-Maadawy WH, Elhusseny Y, Agamy FE, Fahim SA, Balata M.
Genetic Variants and Soluble Isoforms of PD-1/PD-L1 as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma (PDAC) Susceptibility and Prognosis. Biomedicines. 2025; 13(9):2246.
https://doi.org/10.3390/biomedicines13092246
Chicago/Turabian Style
Hassan, Marwa, Walaa H. El-Maadawy, Yasmine Elhusseny, Fatma Elbatol Agamy, Sally A. Fahim, and Mahmoud Balata.
2025. "Genetic Variants and Soluble Isoforms of PD-1/PD-L1 as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma (PDAC) Susceptibility and Prognosis" Biomedicines 13, no. 9: 2246.
https://doi.org/10.3390/biomedicines13092246
APA Style
Hassan, M., El-Maadawy, W. H., Elhusseny, Y., Agamy, F. E., Fahim, S. A., & Balata, M.
(2025). Genetic Variants and Soluble Isoforms of PD-1/PD-L1 as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma (PDAC) Susceptibility and Prognosis. Biomedicines, 13(9), 2246.
https://doi.org/10.3390/biomedicines13092246